Skip to main content
REVVITY, INC. logo

REVVITY, INC. — Investor Relations & Filings

Ticker · RVTY ISIN · US7140461093 LEI · 549300IKL1SDPFI7N655 US Manufacturing
Open in API
Filings indexed 1,579 across all filing types
Latest filing 2026-06-01 Regulatory Filings
Country US United States of America
Listing US RVTY

About REVVITY, INC.

https://www.revvity.com/

Revvity, Inc. is a health science solutions company providing technologies, expertise, and services across the life sciences and diagnostics sectors. The company offers a comprehensive portfolio that supports complete workflows, from initial research and discovery through preclinical and clinical development to diagnostics and cure. Its offerings include a wide range of reagents, consumables, assays, instruments, and software. Revvity also provides specialized contract services for areas such as preclinical drug discovery and clinical genetic testing, alongside licensable technologies. The company serves customers in the pharmaceutical, biotechnology, academic, and diagnostic laboratory markets, as well as contract research organizations.

Recent filings

Filing Released Lang Actions
SD
Regulatory Filings Classification · 82% confidence The document is a specialized disclosure report on SEC Form SD relating to conflict minerals, with an exhibit referencing the Conflict Minerals Report. It is a regulatory compliance filing rather than a financial statement (10-K, IR, etc.), management discussion, or investor presentation. It does not contain substantive financial data or governance changes, but is an SEC-required regulatory filing. Therefore it falls under Regulatory Filings (RNS).
2026-06-01 English
10-Q - REVVITY, INC. (0000031791) (Filer)
Interim / Quarterly Report
2026-05-12 English
8-K - REVVITY, INC. (0000031791) (Filer)
Regulatory Filings Classification · 11% confidence The document is a Current Report on Form 8-K filed with the SEC. It furnishes a press release for Q1 results as Exhibit 99.1 and pro forma financial statements as Exhibit 99.2. It does not itself contain substantive financials beyond referring to attachments, nor is it a standalone annual or interim report. This is a general regulatory submission that doesn’t fit the more specific categories, so it falls under Regulatory Filings.
2026-05-05 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 96% confidence The document is a Form 8-K current report containing Item 5.07 “Submission of Matters to a Vote of Security Holders,” listing detailed vote results for each proposal at the annual meeting. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA), which covers official shareholder vote outcomes. There is no presentation, financial statement, or other primary report content; it solely reports vote tallies.
2026-05-01 English
Major Shareholding Notification 2026
Major Shareholding Notification
2026-04-30 English
SCHEDULE 13G/A - REVVITY, INC. (0000031791) (Subject)
Major Shareholding Notification
2026-03-27 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.